Advancements in antibody-drug conjugates as cancer therapeutics

Advancements in antibody-drug conjugates as cancer therapeutics

Antibody-drug conjugates (ADCs) represent a promising approach in targeted cancer therapy, combining the targeted precision of antibodies with the potency of cytotoxic payloads to selectively target tumour cell whilst minimising off-target effects. This review provides a comprehensive analysis of AD...

Full description

Saved in:
Bibliographic Details
Main Authors: Jung Yin Fong, Zhixin Phuna, Di Yang Chong, Christophorus Manuel Heryanto, Yu Shyan Low, Khang Chiang Oh, Yan Huen Lee, Allan Wee Ren Ng, Lionel Lian Aun In, Michelle Yee Mun Teo
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Journal of the National Cancer Center
Subjects:
Antibody-drug conjugates
Cancer
Targeted therapy
Antibody
Linker
Online Access:http://www.sciencedirect.com/science/article/pii/S2667005425000432
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2667005425000432

Similar Items